Hong Kong Brain PET-MRI Systems Market Analysis Trends and Forecast to 2034: Segmented by (By Phase, By Product Type, By End Use, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Hong Kong · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$0.5 MnPlaceholder estimate
Estimate 2025$0.6 Mn0.1% of the global market
Projected 2034$1.1 Mn 91.7%Adds $0.5 Mn over 9 forecast years
CAGR 2025–20347.5%Faster than 4% of 103 Digital Health markets here
Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Bruker, Mediso Ltd. and 2 more (see all)
Active clinical trials
18 in Hong KongSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 9 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Hong Kong Brain PET-MRI Systems Market Analysis Executive Summary
A brain positron emission tomography scan is a diagnostic x-ray of the brain. It employs a component known as a tracer, which is radioactive, in its attempt to find disease or injury in the brain. A PET scan reveals how the brain and its tissue’s function. Other imaging tests like magnetic resonance imaging and computed axial tomography provide only the structural depiction of the brain and the tissue surrounding it. According to the Lancet Neurology, over 3 billion people globally are suffering from a neurological disorder in 2021.
The Brain PET-MRI Systems market is growing at a rapid pace owing to the rise in the number of neurological disorders, development of imaging systems and an increase in research and development activities. This market consists of integrated PET-MRI, and solo PET-MRI systems for oncology, neurology, and psychiatry fields, with the highest demand in North America and Europe. Nevertheless, there is evidence of risks and limitations, such as high costs and technical feasibility. It is dominated by players like Siemens Healthineers, GE Healthcare, Philips Healthcare, and is also expected to expand as several new technologies and applications are discovered.
Hong Kong Brain PET-MRI Systems market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Hong Kong Brain PET-MRI Systems Market Dynamics
Market Growth Drivers
The brain PET-MRI systems market is expected to expand due to the increasing number of patients with neurological disorders that require better imaging solutions such as Alzheimer and Parkinson diseases. Advances in PET-MRI technologies are improving reconnaissance while the inclination of individuals towards more personalized treatment is paving the way for better imagines. More and more research in this area, rising awareness among the healthcare providers, and a favourable regulatory landscape also contribute to the market growth, with PET-MRI systems being employed in clinical and research use across different branches of medicine.
Opportunity
The opportunities for the development of brain PET-MRI systems in the future include the extension of the role of the method other than neurological disorders, cancer, and cardiovascular diseases, and the use of whole-body imaging. The development of the technology can allow for its use in diagnosing more complex diseases in the future. Moreover, the shift towards more precise and individualized treatments also creates new demand for PET-MRI systems in precise patient-specific approaches. Asia pacific, Latin America and Middle eastern countries are the most likely markets for the company to expand to because with improvement in healthcare, awareness for these technologies will rise.
Market Restraints
There are several obstacles to adopting brain PET-MRI systems, one of the biggest being that acquiring a system costs millions, which makes it difficult for small institutions. The difficulties of installation and maintenance increase further, as it demands professional knowledge and more assets. In other areas, limited reimbursement also impacts the ability to invest in these systems; concerns over radiation exposure in general and particularly for women may also affect the use of these technologies. Further, other imaging modalities and scarcity of knowledge and expertise in healthcare professionals also poses challenges to the integration of these efficient hybrid systems.
Competitive Landscape Brain PET-MRI Systems Market in Hong Kong
July 2024, Positrigo Received FDA Clearance for Breakthrough Brain PET System. The Food and Drug Administration (FDA) has granted 510(k) clearance for the NeuroLF system, which offers dedicated positron emission tomography (PET) imaging of the brain.
February 2024, Philips introduced Smart Quant Neuro 3D, an AI-based quantitative brain imaging tool for MRI. This newly launched product provides healthcare providers with advanced tools to enhance diagnostic confidence.
August 2025, First India-made MRI scanner to be launched for clinical work. The indigenously developed machine is characterised by several innovations, including avoiding reliance on scarcely available liquid helium, bottom-up software design, and customised hardware.
May 2025, Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute. The Cubresa BrainPET is a removeable, high-performing PET scanner, specifically designed for PET/MRI brain imaging.
Mergers and Acquisitions
July 2024, GE HealthCare to acquire AI business from ultrasound firm for $51M, plus more vendor news.
January 2021, GE Healthcare acquires Prismatic Sensors and its advanced photon-counting CT sensors.
Healthcare Policies and Regulatory Landscape for Brain PET-MRI Systems Market in Hong Kong
Brain PET-MRI Systems in Hong Kong: payment and research
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.[1] ClinicalTrials.gov lists 18 studies on Brain PET-MRI Systems that are recruiting, active or about to start in Hong Kong.[2]
[2]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 9 Nov 2026.
Policy changes and Reimbursement scenario
Revolutionary elements in healthcare practices such as the FDA are authorizing more health brain PET-MRI products to ensure that healthcare givers offer enhanced diagnostics to their patients. Out of the observed trends in the field of brain PET-MRI systems, governments are working towards enhancing the policy landscape. In the United States, in early 2020, the CMS increased reimbursement for amyloid PET scans for early diagnosis of Alzheimer’s disease. There are checks in place for the use of brain pet MRI as professional medical societies are coming up with correct and suitable use. However, reimbursement is still a worry, with only very restricted prospects for neurological use in many areas while countries like Japan are expanding the incidence of coverage for diseases like Parkinson’s. Costs are less of an issue for research use, as reimbursement can be requested through grants, however, high costs remain a major concern for clinical use in certain countries.
7.6 MR Solutions Group Product & Services, Strategies & Financials
7.7 Cubresa, Inc. Product & Services, Strategies & Financials
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The brain PET-MRI systems market is segmented based on several key factors, which help in understanding the dynamics and potential growth areas within the market. Here’s a detailed overview of the market segmentation:
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Brain PET-MRI Systems right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Brain PET-MRI Systems in context
Hong Kong compared
People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 18 countries we cover in APAC.[1]
[1]World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
How big is the Brain PET-MRI Systems market in Hong Kong?
Placeholder estimate: about $0.6 Mn in 2025, rising to about $1.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Brain PET-MRI Systems market in Hong Kong growing?
Placeholder estimate: about 7.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Brain PET-MRI Systems market report cover?
The report splits the market by phase (Clinical, Pre-clinical), product type (Traditional PET/MRI Systems, Helium-Free PET/MRI Systems) and end-use (Hospitals, Diagnostic Imaging Centres, Academic and Research Institutes).
Who are the key players in the Brain PET-MRI Systems market?
Key players include Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Bruker, Mediso Ltd. and MR Solutions Group, among 7 companies the report profiles.
What is driving the Brain PET-MRI Systems market?
The brain PET-MRI systems market is expected to expand due to the increasing number of patients with neurological disorders that require better imaging solutions such as Alzheimer and Parkinson diseases.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
How many clinical trials on Brain PET-MRI Systems are running in Hong Kong?
18 studies are recruiting, active or about to start in Hong Kong, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Hong Kong. Retrieved 9 Nov 2026.
How much research is published on Brain PET-MRI Systems?
PubMed lists 994 papers on Brain PET-MRI Systems added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.